-
1دورية أكاديمية
المؤلفون: Fernanda Costa Svedman, Karin Holmsten, Faith Jawdat, Wehazit Hailom, Daniel Alm, Vitali Grozman, Anders Ullén
المصدر: Radiation Oncology, Vol 19, Iss 1, Pp 1-7 (2024)
مصطلحات موضوعية: Stereotactic body radiation therapy, SBRT, Oligometastatic, Oligoprogressive, Urothelial cancer, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1748-717XTest
-
2دورية أكاديمية
المؤلفون: Kristina Viktorsson, Petra Hååg, Carl‐Henrik Shah, Bo Franzén, Vasiliki Arapi, Karin Holmsten, Per Sandström, Rolf Lewensohn, Anders Ullén
المصدر: Molecular Oncology, Vol 16, Iss 20, Pp 3620-3641 (2022)
مصطلحات موضوعية: biomarkers, early treatment response, extracellular vesicles, metastatic urothelial cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Karin Holmsten, Johanna Eknert, Elisabeth Öfverholm, Dimitrios Papantoniou, Faith Jawdat, Ingrida Verbiéné, Anna Laurell, Elin Jänes, Johan Sandzén, Elzbieta Wojtyna-Dziedzic, Ida Lagstam, Karin Söderkvist, Fernanda Costa-Svedman, Fredrik Liedberg, Martin Bruzelius, Ann-Sofie Fransson, Sofia Kjellström, Lise Hoej Omland, Helle Pappot, Anders Ullén
المصدر: Clinical Genitourinary Cancer.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2eaa98b197dddca1cdbc1cce416c2963Test
https://doi.org/10.1016/j.clgc.2023.05.008Test -
4
المؤلفون: Hans Olsson, Gottfrid Sjödahl, Gunilla Chebil, Mattias Höglund, Petter Kollberg, Kristina Lövgren, Johan Abrahamsson, Pontus Eriksson, Anders Ullén, Karin Holmsten, Carina Bernardo, Claes Lindh, Fredrik Liedberg, Iva Johansson, Nour Al Dain Marzouka
المصدر: European Urology. 81:523-532
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Urology, medicine.medical_treatment, Transcriptome, Cystectomy, Basal (phylogenetics), Internal medicine, medicine, Osteopontin, Stage (cooking), Cisplatin, Cancer och onkologi, Chemotherapy, Bladder cancer, biology, business.industry, Hazard ratio, Retrospective cohort study, medicine.disease, Urothelial carcinoma, Molecular subtypes, Luminal, Basal, squamous, Neoadjuvant, Response, Survival, SPP1, Signature, Cancer and Oncology, biology.protein, Immunohistochemistry, business, Immunostaining, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a128a0d0fefbea9fed538dc860538dTest
https://doi.org/10.1016/j.eururo.2021.10.035Test -
5
المؤلفون: Andreas Carus, Karin Holmsten, Helle Pappot, Anders Ullén
المصدر: Carus, A, Holmsten, K, Pappot, H & Ullén, A 2022, ' The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer : still an open question? ', Acta Oncologica, vol. 61, no. 12, pp. 1515-1516 . https://doi.org/10.1080/0284186X.2022.2153620Test
مصطلحات موضوعية: Oncology, Radiology, Nuclear Medicine and imaging, Hematology, General Medicine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46fb38ec146cfa64e010cb27423c8995Test
https://pubmed.ncbi.nlm.nih.gov/36484326Test -
6
المؤلفون: Karin Holmsten, Lise Høj Omland, Anne Birgitte Als, Mads Agerbæk, Line Hammer Dohn, Henriette Lindberg, Niels Viggo Jensen, Andreas Carus, Mette Moe, Abolfazl Hosseini, Cecilia Radkiewicz, Helle Pappot, Anders Ullén
المصدر: Holmsten, K, Omland, L H, Als, A B, Agerbæk, M, Dohn, L H, Lindberg, H, Jensen, N V, Carus, A, Moe, M, Hosseini, A, Radkiewicz, C, Pappot, H & Ullén, A 2022, ' Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer : Three-Week Versus Four-Week Regimen ', Bladder Cancer, vol. 8, no. 1, pp. 71-80 . https://doi.org/10.3233/BLC-211556Test
مصطلحات موضوعية: Oncology, Urology, gemcitabine, cisplatin, Neoadjuvant chemotherapy, muscle invasive bladder cancer
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5eda6329980f4b6fa846cf3a7cefdeTest
https://findresearcher.sdu.dk:8443/ws/files/200459053/blc_2022_8_1_blc_8_1_blc211556_blc_8_blc211556.pdfTest -
7
المؤلفون: Erika Jonsson, Andreas Carus, Hans von der Maase, Mats Hellström, Camilla Mellnert, Niels Viggo Jensen, Cecilia Nilsson, Karin Holmsten, Mads Agerbæk, Helle Pappot, Mette Moe, Anders Ullén, Outi Lahdenperä, Hemming Johansson, Elisabeth Öfverholm, Yvonne Brandberg, Lene Sonne Mouritsen
المصدر: Holmsten, K, Jensen, N V, Mouritsen, L S, Jonsson, E, Mellnert, C, Agerbæk, M, Nilsson, C, Moe, M, Carus, A, Öfverholm, E, Lahdenperä, O, Brandberg, Y, Johansson, H, Hellström, M, Maase, H V D, Pappot, H & Ullén, A 2020, ' Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma : A randomised phase II trial (VINGEM) ', European Journal of Cancer, vol. 127, pp. 173-182 . https://doi.org/10.1016/j.ejca.2019.08.033Test
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Urology, Neutropenia, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Cisplatin-unfit, Carboplatin/gemcitabine, medicine, Renal impairment, Vinflunine/gemcitabine, Chemotherapy, Vinflunine, Performance status, business.industry, Standard treatment, Bladder cancer, medicine.disease, Carboplatin, Gemcitabine, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Urothelial carcinoma, business, Febrile neutropenia, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57970b12a41b177a6b62c235c6c5252aTest
https://findresearcher.sdu.dk:8443/ws/files/159859034/PIIS0959804919307269.pdfTest -
8
المؤلفون: Niels Viggo Jensen, Helle Pappot, Anders Ullén, Carl Henrik Shah, Karin Holmsten, L.H. Dohn, Fredrik Jäderling
المصدر: Oncology Letters
Holmsten, K, Dohn, L, Jensen, N V, Shah, C-H, Jäderling, F, Pappot, H & Ullén, A 2016, ' Vinflunine treatment in patients with metastatic urothelial cancer : A Nordic retrospective multicenter analysis ', Oncology Letters, vol. 12, no. 2, pp. 1293-1300 . https://doi.org/10.3892/ol.2016.4775Testمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Prognostic factors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Medicine, Urothelial cancer, In patient, Platinum-refractory, Vinflunine, Bladder cancer, business.industry, Cancer, prognostic factors, Articles, platinum-refractory, medicine.disease, Molecular medicine, Surgery, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Toxicity, bladder cancer, Corrigendum, business, vinflunine
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d3bd4790fe5a47e75655f246c4a474Test
http://europepmc.org/articles/PMC4950730Test -
9
المؤلفون: Cecilia Ekéus, Mikael Norman, Katarina Åberg, Karin Holmsten, Vania Weibel
المصدر: Pediatrics. 136:1087-1094
مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Population, Mothers, Risk management tools, Risk Assessment, Pregnancy, Risk Factors, medicine, Humans, Registries, education, Sweden, education.field_of_study, business.industry, Obstetrics, Incidence, Incidence (epidemiology), Infant, Newborn, Gestational age, Odds ratio, medicine.disease, Pregnancy Complications, Pediatrics, Perinatology and Child Health, Gestation, Female, Hyperbilirubinemia, Neonatal, Risk assessment, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7389ecef6dc239a81ad53555fcc2786Test
https://doi.org/10.1542/peds.2015-2001Test -
10
المؤلفون: Anders Ullén, Fredrik Jäderling, Per Grybäck, Mads Agerbæk, Helle Pappot, Jeffrey Yachnin, C.-H. Shah, H. Von Der Maase, Karin Holmsten
المصدر: Shah, C H, Pappot, H, Agerbæk, M, Holmsten, K, Jäderling, F, Yachnin, J, Grybäck, P, von der Maase, H & Ullén, A 2019, ' Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor) : Phase I Trial ', Oncologist, vol. 24, no. 6, pp. 745-e213 . https://doi.org/10.1634/theoncologist.2018-0795Test
The Oncologistمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, CELL-CARCINOMA, Cancer Research, MULTICENTER, Kaplan-Meier Estimate, THERAPY, Tyrosine-kinase inhibitor, Carboplatin, DOUBLE-BLIND, chemistry.chemical_compound, 0302 clinical medicine, PLUS, Antineoplastic Combined Chemotherapy Protocols, 030212 general & internal medicine, Chemotherapy-Induced Febrile Neutropenia, Fatigue, Aged, 80 and over, Vinflunine, PLACEBO, Middle Aged, Sorafenib, CHEMOTHERAPY, CANCER, 030220 oncology & carcinogenesis, Hypertension, Female, Hyponatremia, medicine.drug, Adult, medicine.medical_specialty, Neutropenia, Metastatic Urothelial Carcinoma, Maximum Tolerated Dose, medicine.drug_class, Urology, chemistry.chemical_element, Vinblastine, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Humans, Adverse effect, Aged, Carcinoma, Transitional Cell, business.industry, Clinical Trial Results, medicine.disease, 030104 developmental biology, Urinary Bladder Neoplasms, GEMCITABINE, chemistry, Drug Resistance, Neoplasm, Cancer research, Cisplatin, Platinum, business, Febrile neutropenia
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3929a4c4a45f95a3a44374e26cc6ebTest
https://doi.org/10.1634/theoncologist.2018-0795Test